Skip to content

Contribution of PET (positron emission tomography) scans for the preoperative assessment of symptomatic endometriosis lesions: TEP-ENDORUN

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-520423-88-00
Acronym
2013/CHU/12
Enrollment
15
Registered
2025-01-29
Start date
2025-02-01
Completion date
2025-04-24
Last updated
2025-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Brief summary

Total number of endometriosis lesions diagnosed by PET scan in our 10 patients compared with the number of lesions described during surgery., Number of locations identified by PET scan compared with number of locations identified during surgery.

Detailed description

SUV threshold to identify endometriosis lesions., Number of lesions visible on PET scan and not visible on MRI, location on PET scan compared with MRI

Interventions

DRUGFurosemide 10 mg/ml solution for injection
DRUGGLUCOTRACE 185 MBq/ml solution injectable

Sponsors

Centre Hospitalier Universitaire De La Reunion
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Design outcomes

Primary

MeasureTime frame
Total number of endometriosis lesions diagnosed by PET scan in our 10 patients compared with the number of lesions described during surgery., Number of locations identified by PET scan compared with number of locations identified during surgery.

Secondary

MeasureTime frame
SUV threshold to identify endometriosis lesions., Number of lesions visible on PET scan and not visible on MRI, location on PET scan compared with MRI

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026